Gold(III)-Dithiocarbamato Peptidomimetics in the Forefront of the Targeted Anticancer Therapy: Preclinical Studies against Human Breast Neoplasia

Chiara Nardon(The Barbara Ann Karmanos Cancer Institute), Q. Ping Dou(Wayne State University)
PLoS ONE
January 2, 2014
Cited by 48


Related Papers